The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Antiviral Oral Liquid Market Research Report 2025
Synopsis
Antiviral Oral liquids are homogeneous liquid preparations, usually contains a solution, an emulsion or a suspension of one or more active ingredients in a suitable liquid base.
The global Antiviral Oral Liquid market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Antiviral Oral Liquid is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Antiviral Oral Liquid is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Antiviral Oral Liquid in Adults is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Antiviral Oral Liquid include Pfizer, Roche, Novartis, Merck, GlaxoSmithKline, Johnson & Johnson, AbbVie, Sanofi and Bristol-Myers Squibb, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Antiviral Oral Liquid, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiviral Oral Liquid.
Report Scope
The Antiviral Oral Liquid market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antiviral Oral Liquid market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antiviral Oral Liquid companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Roche
Novartis
Merck
GlaxoSmithKline
Johnson & Johnson
AbbVie
Sanofi
Bristol-Myers Squibb
AstraZeneca
Eli Lilly
Novo Nordisk
Amgen
Gilead Sciences
CSL
Takeda Pharmaceuticals
Bayer
Celgene
Merck KGaA
Allergan
Segment by Type
Syrup
Oral suspension
Oral solution
Oral drop
Oral emulsion
Mixture
Segment by Application
Adults
Children
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antiviral Oral Liquid companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Antiviral Oral liquids are homogeneous liquid preparations, usually contains a solution, an emulsion or a suspension of one or more active ingredients in a suitable liquid base.
The global Antiviral Oral Liquid market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Antiviral Oral Liquid is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Antiviral Oral Liquid is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Antiviral Oral Liquid in Adults is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Antiviral Oral Liquid include Pfizer, Roche, Novartis, Merck, GlaxoSmithKline, Johnson & Johnson, AbbVie, Sanofi and Bristol-Myers Squibb, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Antiviral Oral Liquid, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiviral Oral Liquid.
Report Scope
The Antiviral Oral Liquid market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antiviral Oral Liquid market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antiviral Oral Liquid companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Roche
Novartis
Merck
GlaxoSmithKline
Johnson & Johnson
AbbVie
Sanofi
Bristol-Myers Squibb
AstraZeneca
Eli Lilly
Novo Nordisk
Amgen
Gilead Sciences
CSL
Takeda Pharmaceuticals
Bayer
Celgene
Merck KGaA
Allergan
Segment by Type
Syrup
Oral suspension
Oral solution
Oral drop
Oral emulsion
Mixture
Segment by Application
Adults
Children
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antiviral Oral Liquid companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antiviral Oral Liquid Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Syrup
1.2.3 Oral suspension
1.2.4 Oral solution
1.2.5 Oral drop
1.2.6 Oral emulsion
1.2.7 Mixture
1.3 Market by Application
1.3.1 Global Antiviral Oral Liquid Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Adults
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antiviral Oral Liquid Market Perspective (2019-2030)
2.2 Antiviral Oral Liquid Growth Trends by Region
2.2.1 Global Antiviral Oral Liquid Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Antiviral Oral Liquid Historic Market Size by Region (2019-2024)
2.2.3 Antiviral Oral Liquid Forecasted Market Size by Region (2025-2030)
2.3 Antiviral Oral Liquid Market Dynamics
2.3.1 Antiviral Oral Liquid Industry Trends
2.3.2 Antiviral Oral Liquid Market Drivers
2.3.3 Antiviral Oral Liquid Market Challenges
2.3.4 Antiviral Oral Liquid Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antiviral Oral Liquid Players by Revenue
3.1.1 Global Top Antiviral Oral Liquid Players by Revenue (2019-2024)
3.1.2 Global Antiviral Oral Liquid Revenue Market Share by Players (2019-2024)
3.2 Global Antiviral Oral Liquid Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antiviral Oral Liquid Revenue
3.4 Global Antiviral Oral Liquid Market Concentration Ratio
3.4.1 Global Antiviral Oral Liquid Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiviral Oral Liquid Revenue in 2023
3.5 Antiviral Oral Liquid Key Players Head office and Area Served
3.6 Key Players Antiviral Oral Liquid Product Solution and Service
3.7 Date of Enter into Antiviral Oral Liquid Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antiviral Oral Liquid Breakdown Data by Type
4.1 Global Antiviral Oral Liquid Historic Market Size by Type (2019-2024)
4.2 Global Antiviral Oral Liquid Forecasted Market Size by Type (2025-2030)
5 Antiviral Oral Liquid Breakdown Data by Application
5.1 Global Antiviral Oral Liquid Historic Market Size by Application (2019-2024)
5.2 Global Antiviral Oral Liquid Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Antiviral Oral Liquid Market Size (2019-2030)
6.2 North America Antiviral Oral Liquid Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Antiviral Oral Liquid Market Size by Country (2019-2024)
6.4 North America Antiviral Oral Liquid Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antiviral Oral Liquid Market Size (2019-2030)
7.2 Europe Antiviral Oral Liquid Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Antiviral Oral Liquid Market Size by Country (2019-2024)
7.4 Europe Antiviral Oral Liquid Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antiviral Oral Liquid Market Size (2019-2030)
8.2 Asia-Pacific Antiviral Oral Liquid Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Antiviral Oral Liquid Market Size by Region (2019-2024)
8.4 Asia-Pacific Antiviral Oral Liquid Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antiviral Oral Liquid Market Size (2019-2030)
9.2 Latin America Antiviral Oral Liquid Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Antiviral Oral Liquid Market Size by Country (2019-2024)
9.4 Latin America Antiviral Oral Liquid Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antiviral Oral Liquid Market Size (2019-2030)
10.2 Middle East & Africa Antiviral Oral Liquid Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Antiviral Oral Liquid Market Size by Country (2019-2024)
10.4 Middle East & Africa Antiviral Oral Liquid Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Antiviral Oral Liquid Introduction
11.1.4 Pfizer Revenue in Antiviral Oral Liquid Business (2019-2024)
11.1.5 Pfizer Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Antiviral Oral Liquid Introduction
11.2.4 Roche Revenue in Antiviral Oral Liquid Business (2019-2024)
11.2.5 Roche Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Antiviral Oral Liquid Introduction
11.3.4 Novartis Revenue in Antiviral Oral Liquid Business (2019-2024)
11.3.5 Novartis Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Antiviral Oral Liquid Introduction
11.4.4 Merck Revenue in Antiviral Oral Liquid Business (2019-2024)
11.4.5 Merck Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Antiviral Oral Liquid Introduction
11.5.4 GlaxoSmithKline Revenue in Antiviral Oral Liquid Business (2019-2024)
11.5.5 GlaxoSmithKline Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Antiviral Oral Liquid Introduction
11.6.4 Johnson & Johnson Revenue in Antiviral Oral Liquid Business (2019-2024)
11.6.5 Johnson & Johnson Recent Development
11.7 AbbVie
11.7.1 AbbVie Company Detail
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Antiviral Oral Liquid Introduction
11.7.4 AbbVie Revenue in Antiviral Oral Liquid Business (2019-2024)
11.7.5 AbbVie Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Detail
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Antiviral Oral Liquid Introduction
11.8.4 Sanofi Revenue in Antiviral Oral Liquid Business (2019-2024)
11.8.5 Sanofi Recent Development
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Detail
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb Antiviral Oral Liquid Introduction
11.9.4 Bristol-Myers Squibb Revenue in Antiviral Oral Liquid Business (2019-2024)
11.9.5 Bristol-Myers Squibb Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Detail
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca Antiviral Oral Liquid Introduction
11.10.4 AstraZeneca Revenue in Antiviral Oral Liquid Business (2019-2024)
11.10.5 AstraZeneca Recent Development
11.11 Eli Lilly
11.11.1 Eli Lilly Company Detail
11.11.2 Eli Lilly Business Overview
11.11.3 Eli Lilly Antiviral Oral Liquid Introduction
11.11.4 Eli Lilly Revenue in Antiviral Oral Liquid Business (2019-2024)
11.11.5 Eli Lilly Recent Development
11.12 Novo Nordisk
11.12.1 Novo Nordisk Company Detail
11.12.2 Novo Nordisk Business Overview
11.12.3 Novo Nordisk Antiviral Oral Liquid Introduction
11.12.4 Novo Nordisk Revenue in Antiviral Oral Liquid Business (2019-2024)
11.12.5 Novo Nordisk Recent Development
11.13 Amgen
11.13.1 Amgen Company Detail
11.13.2 Amgen Business Overview
11.13.3 Amgen Antiviral Oral Liquid Introduction
11.13.4 Amgen Revenue in Antiviral Oral Liquid Business (2019-2024)
11.13.5 Amgen Recent Development
11.14 Gilead Sciences
11.14.1 Gilead Sciences Company Detail
11.14.2 Gilead Sciences Business Overview
11.14.3 Gilead Sciences Antiviral Oral Liquid Introduction
11.14.4 Gilead Sciences Revenue in Antiviral Oral Liquid Business (2019-2024)
11.14.5 Gilead Sciences Recent Development
11.15 CSL
11.15.1 CSL Company Detail
11.15.2 CSL Business Overview
11.15.3 CSL Antiviral Oral Liquid Introduction
11.15.4 CSL Revenue in Antiviral Oral Liquid Business (2019-2024)
11.15.5 CSL Recent Development
11.16 Takeda Pharmaceuticals
11.16.1 Takeda Pharmaceuticals Company Detail
11.16.2 Takeda Pharmaceuticals Business Overview
11.16.3 Takeda Pharmaceuticals Antiviral Oral Liquid Introduction
11.16.4 Takeda Pharmaceuticals Revenue in Antiviral Oral Liquid Business (2019-2024)
11.16.5 Takeda Pharmaceuticals Recent Development
11.17 Bayer
11.17.1 Bayer Company Detail
11.17.2 Bayer Business Overview
11.17.3 Bayer Antiviral Oral Liquid Introduction
11.17.4 Bayer Revenue in Antiviral Oral Liquid Business (2019-2024)
11.17.5 Bayer Recent Development
11.18 Celgene
11.18.1 Celgene Company Detail
11.18.2 Celgene Business Overview
11.18.3 Celgene Antiviral Oral Liquid Introduction
11.18.4 Celgene Revenue in Antiviral Oral Liquid Business (2019-2024)
11.18.5 Celgene Recent Development
11.19 Merck KGaA
11.19.1 Merck KGaA Company Detail
11.19.2 Merck KGaA Business Overview
11.19.3 Merck KGaA Antiviral Oral Liquid Introduction
11.19.4 Merck KGaA Revenue in Antiviral Oral Liquid Business (2019-2024)
11.19.5 Merck KGaA Recent Development
11.20 Allergan
11.20.1 Allergan Company Detail
11.20.2 Allergan Business Overview
11.20.3 Allergan Antiviral Oral Liquid Introduction
11.20.4 Allergan Revenue in Antiviral Oral Liquid Business (2019-2024)
11.20.5 Allergan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Antiviral Oral Liquid Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Syrup
Table 3. Key Players of Oral suspension
Table 4. Key Players of Oral solution
Table 5. Key Players of Oral drop
Table 6. Key Players of Oral emulsion
Table 7. Key Players of Mixture
Table 8. Global Antiviral Oral Liquid Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Antiviral Oral Liquid Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Antiviral Oral Liquid Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Antiviral Oral Liquid Market Share by Region (2019-2024)
Table 12. Global Antiviral Oral Liquid Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Antiviral Oral Liquid Market Share by Region (2025-2030)
Table 14. Antiviral Oral Liquid Market Trends
Table 15. Antiviral Oral Liquid Market Drivers
Table 16. Antiviral Oral Liquid Market Challenges
Table 17. Antiviral Oral Liquid Market Restraints
Table 18. Global Antiviral Oral Liquid Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Antiviral Oral Liquid Market Share by Players (2019-2024)
Table 20. Global Top Antiviral Oral Liquid Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral Oral Liquid as of 2023)
Table 21. Ranking of Global Top Antiviral Oral Liquid Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Antiviral Oral Liquid Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Antiviral Oral Liquid Product Solution and Service
Table 25. Date of Enter into Antiviral Oral Liquid Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Antiviral Oral Liquid Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Antiviral Oral Liquid Revenue Market Share by Type (2019-2024)
Table 29. Global Antiviral Oral Liquid Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Antiviral Oral Liquid Revenue Market Share by Type (2025-2030)
Table 31. Global Antiviral Oral Liquid Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Antiviral Oral Liquid Revenue Market Share by Application (2019-2024)
Table 33. Global Antiviral Oral Liquid Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Antiviral Oral Liquid Revenue Market Share by Application (2025-2030)
Table 35. North America Antiviral Oral Liquid Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Antiviral Oral Liquid Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Antiviral Oral Liquid Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Antiviral Oral Liquid Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Antiviral Oral Liquid Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Antiviral Oral Liquid Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Antiviral Oral Liquid Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Antiviral Oral Liquid Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Antiviral Oral Liquid Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Antiviral Oral Liquid Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Antiviral Oral Liquid Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Antiviral Oral Liquid Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Antiviral Oral Liquid Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Antiviral Oral Liquid Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Antiviral Oral Liquid Market Size by Country (2025-2030) & (US$ Million)
Table 50. Pfizer Company Detail
Table 51. Pfizer Business Overview
Table 52. Pfizer Antiviral Oral Liquid Product
Table 53. Pfizer Revenue in Antiviral Oral Liquid Business (2019-2024) & (US$ Million)
Table 54. Pfizer Recent Development
Table 55. Roche Company Detail
Table 56. Roche Business Overview
Table 57. Roche Antiviral Oral Liquid Product
Table 58. Roche Revenue in Antiviral Oral Liquid Business (2019-2024) & (US$ Million)
Table 59. Roche Recent Development
Table 60. Novartis Company Detail
Table 61. Novartis Business Overview
Table 62. Novartis Antiviral Oral Liquid Product
Table 63. Novartis Revenue in Antiviral Oral Liquid Business (2019-2024) & (US$ Million)
Table 64. Novartis Recent Development
Table 65. Merck Company Detail
Table 66. Merck Business Overview
Table 67. Merck Antiviral Oral Liquid Product
Table 68. Merck Revenue in Antiviral Oral Liquid Business (2019-2024) & (US$ Million)
Table 69. Merck Recent Development
Table 70. GlaxoSmithKline Company Detail
Table 71. GlaxoSmithKline Business Overview
Table 72. GlaxoSmithKline Antiviral Oral Liquid Product
Table 73. GlaxoSmithKline Revenue in Antiviral Oral Liquid Business (2019-2024) & (US$ Million)
Table 74. GlaxoSmithKline Recent Development
Table 75. Johnson & Johnson Company Detail
Table 76. Johnson & Johnson Business Overview
Table 77. Johnson & Johnson Antiviral Oral Liquid Product
Table 78. Johnson & Johnson Revenue in Antiviral Oral Liquid Business (2019-2024) & (US$ Million)
Table 79. Johnson & Johnson Recent Development
Table 80. AbbVie Company Detail
Table 81. AbbVie Business Overview
Table 82. AbbVie Antiviral Oral Liquid Product
Table 83. AbbVie Revenue in Antiviral Oral Liquid Business (2019-2024) & (US$ Million)
Table 84. AbbVie Recent Development
Table 85. Sanofi Company Detail
Table 86. Sanofi Business Overview
Table 87. Sanofi Antiviral Oral Liquid Product
Table 88. Sanofi Revenue in Antiviral Oral Liquid Business (2019-2024) & (US$ Million)
Table 89. Sanofi Recent Development
Table 90. Bristol-Myers Squibb Company Detail
Table 91. Bristol-Myers Squibb Business Overview
Table 92. Bristol-Myers Squibb Antiviral Oral Liquid Product
Table 93. Bristol-Myers Squibb Revenue in Antiviral Oral Liquid Business (2019-2024) & (US$ Million)
Table 94. Bristol-Myers Squibb Recent Development
Table 95. AstraZeneca Company Detail
Table 96. AstraZeneca Business Overview
Table 97. AstraZeneca Antiviral Oral Liquid Product
Table 98. AstraZeneca Revenue in Antiviral Oral Liquid Business (2019-2024) & (US$ Million)
Table 99. AstraZeneca Recent Development
Table 100. Eli Lilly Company Detail
Table 101. Eli Lilly Business Overview
Table 102. Eli Lilly Antiviral Oral Liquid Product
Table 103. Eli Lilly Revenue in Antiviral Oral Liquid Business (2019-2024) & (US$ Million)
Table 104. Eli Lilly Recent Development
Table 105. Novo Nordisk Company Detail
Table 106. Novo Nordisk Business Overview
Table 107. Novo Nordisk Antiviral Oral Liquid Product
Table 108. Novo Nordisk Revenue in Antiviral Oral Liquid Business (2019-2024) & (US$ Million)
Table 109. Novo Nordisk Recent Development
Table 110. Amgen Company Detail
Table 111. Amgen Business Overview
Table 112. Amgen Antiviral Oral Liquid Product
Table 113. Amgen Revenue in Antiviral Oral Liquid Business (2019-2024) & (US$ Million)
Table 114. Amgen Recent Development
Table 115. Gilead Sciences Company Detail
Table 116. Gilead Sciences Business Overview
Table 117. Gilead Sciences Antiviral Oral Liquid Product
Table 118. Gilead Sciences Revenue in Antiviral Oral Liquid Business (2019-2024) & (US$ Million)
Table 119. Gilead Sciences Recent Development
Table 120. CSL Company Detail
Table 121. CSL Business Overview
Table 122. CSL Antiviral Oral Liquid Product
Table 123. CSL Revenue in Antiviral Oral Liquid Business (2019-2024) & (US$ Million)
Table 124. CSL Recent Development
Table 125. Takeda Pharmaceuticals Company Detail
Table 126. Takeda Pharmaceuticals Business Overview
Table 127. Takeda Pharmaceuticals Antiviral Oral Liquid Product
Table 128. Takeda Pharmaceuticals Revenue in Antiviral Oral Liquid Business (2019-2024) & (US$ Million)
Table 129. Takeda Pharmaceuticals Recent Development
Table 130. Bayer Company Detail
Table 131. Bayer Business Overview
Table 132. Bayer Antiviral Oral Liquid Product
Table 133. Bayer Revenue in Antiviral Oral Liquid Business (2019-2024) & (US$ Million)
Table 134. Bayer Recent Development
Table 135. Celgene Company Detail
Table 136. Celgene Business Overview
Table 137. Celgene Antiviral Oral Liquid Product
Table 138. Celgene Revenue in Antiviral Oral Liquid Business (2019-2024) & (US$ Million)
Table 139. Celgene Recent Development
Table 140. Merck KGaA Company Detail
Table 141. Merck KGaA Business Overview
Table 142. Merck KGaA Antiviral Oral Liquid Product
Table 143. Merck KGaA Revenue in Antiviral Oral Liquid Business (2019-2024) & (US$ Million)
Table 144. Merck KGaA Recent Development
Table 145. Allergan Company Detail
Table 146. Allergan Business Overview
Table 147. Allergan Antiviral Oral Liquid Product
Table 148. Allergan Revenue in Antiviral Oral Liquid Business (2019-2024) & (US$ Million)
Table 149. Allergan Recent Development
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antiviral Oral Liquid Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Antiviral Oral Liquid Market Share by Type: 2023 VS 2030
Figure 3. Syrup Features
Figure 4. Oral suspension Features
Figure 5. Oral solution Features
Figure 6. Oral drop Features
Figure 7. Oral emulsion Features
Figure 8. Mixture Features
Figure 9. Global Antiviral Oral Liquid Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Antiviral Oral Liquid Market Share by Application: 2023 VS 2030
Figure 11. Adults Case Studies
Figure 12. Children Case Studies
Figure 13. Antiviral Oral Liquid Report Years Considered
Figure 14. Global Antiviral Oral Liquid Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Antiviral Oral Liquid Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Antiviral Oral Liquid Market Share by Region: 2023 VS 2030
Figure 17. Global Antiviral Oral Liquid Market Share by Players in 2023
Figure 18. Global Top Antiviral Oral Liquid Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral Oral Liquid as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Antiviral Oral Liquid Revenue in 2023
Figure 20. North America Antiviral Oral Liquid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Antiviral Oral Liquid Market Share by Country (2019-2030)
Figure 22. United States Antiviral Oral Liquid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Antiviral Oral Liquid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Antiviral Oral Liquid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Antiviral Oral Liquid Market Share by Country (2019-2030)
Figure 26. Germany Antiviral Oral Liquid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Antiviral Oral Liquid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Antiviral Oral Liquid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Antiviral Oral Liquid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Antiviral Oral Liquid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Antiviral Oral Liquid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Antiviral Oral Liquid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Antiviral Oral Liquid Market Share by Region (2019-2030)
Figure 34. China Antiviral Oral Liquid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Antiviral Oral Liquid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Antiviral Oral Liquid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Antiviral Oral Liquid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Antiviral Oral Liquid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Antiviral Oral Liquid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Antiviral Oral Liquid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Antiviral Oral Liquid Market Share by Country (2019-2030)
Figure 42. Mexico Antiviral Oral Liquid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Antiviral Oral Liquid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Antiviral Oral Liquid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Antiviral Oral Liquid Market Share by Country (2019-2030)
Figure 46. Turkey Antiviral Oral Liquid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Antiviral Oral Liquid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Pfizer Revenue Growth Rate in Antiviral Oral Liquid Business (2019-2024)
Figure 49. Roche Revenue Growth Rate in Antiviral Oral Liquid Business (2019-2024)
Figure 50. Novartis Revenue Growth Rate in Antiviral Oral Liquid Business (2019-2024)
Figure 51. Merck Revenue Growth Rate in Antiviral Oral Liquid Business (2019-2024)
Figure 52. GlaxoSmithKline Revenue Growth Rate in Antiviral Oral Liquid Business (2019-2024)
Figure 53. Johnson & Johnson Revenue Growth Rate in Antiviral Oral Liquid Business (2019-2024)
Figure 54. AbbVie Revenue Growth Rate in Antiviral Oral Liquid Business (2019-2024)
Figure 55. Sanofi Revenue Growth Rate in Antiviral Oral Liquid Business (2019-2024)
Figure 56. Bristol-Myers Squibb Revenue Growth Rate in Antiviral Oral Liquid Business (2019-2024)
Figure 57. AstraZeneca Revenue Growth Rate in Antiviral Oral Liquid Business (2019-2024)
Figure 58. Eli Lilly Revenue Growth Rate in Antiviral Oral Liquid Business (2019-2024)
Figure 59. Novo Nordisk Revenue Growth Rate in Antiviral Oral Liquid Business (2019-2024)
Figure 60. Amgen Revenue Growth Rate in Antiviral Oral Liquid Business (2019-2024)
Figure 61. Gilead Sciences Revenue Growth Rate in Antiviral Oral Liquid Business (2019-2024)
Figure 62. CSL Revenue Growth Rate in Antiviral Oral Liquid Business (2019-2024)
Figure 63. Takeda Pharmaceuticals Revenue Growth Rate in Antiviral Oral Liquid Business (2019-2024)
Figure 64. Bayer Revenue Growth Rate in Antiviral Oral Liquid Business (2019-2024)
Figure 65. Celgene Revenue Growth Rate in Antiviral Oral Liquid Business (2019-2024)
Figure 66. Merck KGaA Revenue Growth Rate in Antiviral Oral Liquid Business (2019-2024)
Figure 67. Allergan Revenue Growth Rate in Antiviral Oral Liquid Business (2019-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
